Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$5.63
-2.3%
$2.83
$1.26
$46.50
$21.23M2.7417.04 million shs660,497 shs
Fonar Corporation stock logo
FONR
Fonar
$19.09
$18.83
$13.62
$19.16
$117.79M0.95140,673 shsN/A
Nyxoah SA stock logo
NYXH
Nyxoah
$1.45
-49.7%
$3.02
$1.31
$8.59
$111.63M1.5541,660 shs2.44 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.18
-7.8%
$1.20
$0.92
$1.92
$110.38M2.31191,185 shs157,244 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
+11.41%-48.53%+262.26%+172.99%-33.49%
Fonar Corporation stock logo
FONR
Fonar
+0.04%0.00%+1.01%+3.24%+32.11%
Nyxoah SA stock logo
NYXH
Nyxoah
+0.35%-3.68%-3.03%-22.99%-62.69%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
0.00%-0.78%+2.40%+9.40%+14.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$5.63
-2.3%
$2.83
$1.26
$46.50
$21.23M2.7417.04 million shs660,497 shs
Fonar Corporation stock logo
FONR
Fonar
$19.09
$18.83
$13.62
$19.16
$117.79M0.95140,673 shsN/A
Nyxoah SA stock logo
NYXH
Nyxoah
$1.45
-49.7%
$3.02
$1.31
$8.59
$111.63M1.5541,660 shs2.44 million shs
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
$1.18
-7.8%
$1.20
$0.92
$1.92
$110.38M2.31191,185 shs157,244 shs
5G Stocks: The Path Forward is Profitable Cover

Click the link to see MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
+11.41%-48.53%+262.26%+172.99%-33.49%
Fonar Corporation stock logo
FONR
Fonar
+0.04%0.00%+1.01%+3.24%+32.11%
Nyxoah SA stock logo
NYXH
Nyxoah
+0.35%-3.68%-3.03%-22.99%-62.69%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
0.00%-0.78%+2.40%+9.40%+14.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
2.00
Hold$67.501,098.93% Upside
Fonar Corporation stock logo
FONR
Fonar
2.00
HoldN/AN/A
Nyxoah SA stock logo
NYXH
Nyxoah
2.25
Hold$7.67428.74% Upside
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2.00
Hold$3.50196.61% Upside

Current Analyst Ratings Breakdown

Latest CODX, FONR, NYXH, and VANI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/26/2026
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
UpgradeSell (E+)Sell (D-)
5/22/2026
Nyxoah SA stock logo
NYXH
Nyxoah
DowngradeSell (D-)Sell (E+)
5/13/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Reiterated RatingOverweight$9.00 ➝ $7.00
5/12/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Reiterated RatingBuyHold$8.00 ➝ $5.00
5/11/2026
Nyxoah SA stock logo
NYXH
Nyxoah
UpgradeSell (E+)Sell (D-)
4/22/2026
Nyxoah SA stock logo
NYXH
Nyxoah
DowngradeSell (D-)Sell (E+)
4/10/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Lower Price TargetBuy$10.00 ➝ $8.00
4/7/2026
Fonar Corporation stock logo
FONR
Fonar
Reiterated RatingHold (C)
3/31/2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
Lower Price TargetBuy$4.00 ➝ $3.50
3/23/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Reiterated RatingOverweight$11.00
3/20/2026
Nyxoah SA stock logo
NYXH
Nyxoah
Lower Price TargetBuy$11.00 ➝ $10.00
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
$620K33.51N/AN/A$9.14 per share0.62
Fonar Corporation stock logo
FONR
Fonar
$104.35M1.13$2.10 per share9.09$25.81 per share0.74
Nyxoah SA stock logo
NYXH
Nyxoah
$11.33M4.96N/AN/A$1.43 per share1.01
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/A$0.20 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$46.90M-$15.77N/AN/AN/A-6,760.63%-164.92%-141.15%8/14/2026 (Estimated)
Fonar Corporation stock logo
FONR
Fonar
$8.33M$1.0019.09N/AN/A6.35%4.12%3.07%N/A
Nyxoah SA stock logo
NYXH
Nyxoah
-$101.92M-$2.48N/AN/AN/A-543.21%-163.73%-80.24%8/5/2026 (Estimated)
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$26.61M-$0.40N/AN/AN/AN/A-264.04%-79.85%8/12/2026 (Estimated)

Latest CODX, FONR, NYXH, and VANI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/14/2026Q1 2026
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$3.75-$4.06-$0.31-$4.06$0.13 million$0.15 million
5/13/2026Q1 2026
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.08-$0.08N/A-$0.08N/AN/A
5/12/2026Q1 2026
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.54-$0.43+$0.11-$0.43$7.05 million$7.38 million
5/11/2026Q3 2026
Fonar Corporation stock logo
FONR
Fonar
N/A$0.24N/A$0.24N/A$26.47 million
3/31/2026Q4 2025
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
-$3.90-$16.65-$12.75-$16.65$0.13 million$0.26 million
3/26/2026Q4 2025
Nyxoah SA stock logo
NYXH
Nyxoah
-$0.65-$0.68-$0.03-$0.43$5.70 million$7.38 million
3/26/2026Q4 2025
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
-$0.10-$0.09+$0.01-$0.09N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/AN/AN/AN/AN/A
Fonar Corporation stock logo
FONR
Fonar
N/AN/AN/AN/AN/A
Nyxoah SA stock logo
NYXH
Nyxoah
N/AN/AN/AN/AN/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
N/A
2.28
2.09
Fonar Corporation stock logo
FONR
Fonar
N/A
9.18
9.00
Nyxoah SA stock logo
NYXH
Nyxoah
0.53
0.99
0.88
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
N/A
3.18
3.18

Institutional Ownership

CompanyInstitutional Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
14.99%
Fonar Corporation stock logo
FONR
Fonar
50.64%
Nyxoah SA stock logo
NYXH
Nyxoah
N/A
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
6.78%

Insider Ownership

CompanyInsider Ownership
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
5.40%
Fonar Corporation stock logo
FONR
Fonar
7.93%
Nyxoah SA stock logo
NYXH
Nyxoah
17.11%
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
53.30%
CompanyEmployeesShares OutstandingFree FloatOptionable
Co-Diagnostics, Inc. stock logo
CODX
Co-Diagnostics
1003.69 million3.49 millionOptionable
Fonar Corporation stock logo
FONR
Fonar
4806.17 million5.68 millionNot Optionable
Nyxoah SA stock logo
NYXH
Nyxoah
11038.76 million32.13 millionNot Optionable
Vivani Medical, Inc. stock logo
VANI
Vivani Medical
2086.24 million40.27 millionOptionable

Recent News About These Companies

Vivani completes first-in-human study of GLP-1 implant

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Co-Diagnostics stock logo

Co-Diagnostics NASDAQ:CODX

$5.63 -0.13 (-2.26%)
Closing price 04:00 PM Eastern
Extended Trading
$5.75 +0.12 (+2.13%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Fonar stock logo

Fonar NASDAQ:FONR

$19.09 0.00 (0.00%)
As of 06/4/2026

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services. It provides Upright MRI scanner that allows patients to be scanned in weight-bearing conditions, such as standing, sitting, bending, or lying down. The company also offers non-medical management, including administrative services, billing and collection services, credentialing services, contract negotiations, compliance consulting, purchasing IT services, hiring, conducting interviews, training, supervision and management of non-medical personnel, storage of medical records, office space, equipment, repair maintenance services, accounting, assistance with compliance matters, and development and implementation of practice growth and marketing strategies. It owns and operates diagnostic imaging facilities in Florida; and manages MRI scanning facilities. The company markets its scanners to private diagnostic imaging centers and hospital outpatient imaging facilities. FONAR Corporation was founded in 1970 and is based in Melville, New York.

Nyxoah stock logo

Nyxoah NASDAQ:NYXH

$1.45 -1.43 (-49.65%)
Closing price 04:00 PM Eastern
Extended Trading
$1.52 +0.07 (+4.62%)
As of 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company's lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Vivani Medical stock logo

Vivani Medical NASDAQ:VANI

$1.18 -0.10 (-7.81%)
Closing price 04:00 PM Eastern
Extended Trading
$1.20 +0.02 (+1.69%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.